Milestone Pharmaceuticals Starts Phase 3 Trial of...
Category : Clinical Trial Update 25 August 2026First Patient Enrolled in ReVeRA-301 Study Milestone Pharmaceuticals Inc. has enrolled the first...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Rznomics Joins Lilly Gateway Labs in San Diego to...
Category : Licensing/Collaboration Deal 25 August 2026Rznomics Inc., a South Korean clinical-stage biopharmaceutical company focused on RNA-based gene the...
Glenmark Launches Calcium Gluconate Injection in t...
Category : Approval/Launch 22 August 2026New Injectable Product Targets the U.S. Institutional Healthcare Market Glenmark Pharmaceuticals...
CureGene Doses First Subject in Phase I Trial of O...
Category : Clinical Trial Update 22 August 2026Phase I study begins in Australia CureGene Pharmaceutical has announced that the first subject ha...
Ultragenyx Gets FDA Accelerated Approval for Gengl...
Category : Approval/Launch 21 August 2026First Approved Therapy From Ultragenyx Directly Targets the Root Cause of GSDIa Ultragenyx Pharma...
Latest Newsletter Post
-
Rznomics Joins Lilly Gateway Labs i..
25 August 2026
-
Milestone Pharmaceuticals Starts Ph..
25 August 2026
-
CureGene Doses First Subject in Pha..
22 August 2026
-
Glenmark Launches Calcium Gluconate..
22 August 2026
-
Bayer to Present 11 Cardiovascular..
21 August 2026
